RemeGen Co., Ltd. released its monthly return for the period ended November 30, 2025, detailing share capital movements for both its Hong Kong-listed H shares (stock code 09995) and Shanghai-listed A shares (stock code 688331).
According to the filing, the company’s H-share capital remained at 208,581,239 issued shares, with no change in treasury shares. Meanwhile, A-share capital increased by 102,000 shares, bringing the total to 355,129,004. The increase derived from the partial attribution of restricted shares under the 2022 A Share Incentive Scheme.
At month-end, total authorized or registered share capital stood at RMB563,710,243, comprising RMB208,581,239 for H shares and RMB355,129,004 for A shares. The filing confirmed there were no other warrant issuances, convertibles, or treasury share movements during the period.
Comments